• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Nasal Cellulitis: MRSA Infection of the Nose

Article

The nasal cellulitis that affects this 39-year-old woman began as right intranasal folliculitis.

The nasal cellulitis that affects this 39-year-old woman began as right intranasal folliculitis. Because the patient was sensitive to many antibiotics, oral ciprofloxacin was prescribed.

Robert P. Blereau, MD, of Morgan City, La, writes that the patient's nasal erythema began to clear shortly after antibiotic therapy was initiated. However, 5 days into treatment, 2 pustules at the right side of the nose started to drain, and the erythema worsened. Apparently, resistance to the ciprofloxacin had developed.

Culture and sensitivity studies of the nasal drainage revealed methicillin-resistant Staphylococcus aureus, which was sensitive to vancomycin, trimethoprim/sulfamethoxazole, gentamicin, clindamycin, and rifampin. The patient was given intravenous vancomycin and oral rifampin for 2 weeks; this regimen cured the infection.

Dr Blereau comments that methicillin-resistant S aureus (MRSA) has long been recognized as a major nosocomial pathogen. He emphasizes that this case illustrates an occurrence of community-acquired MRSA.
 

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
© 2025 MJH Life Sciences

All rights reserved.